SEC Form 4 · accession 0001209191-18-018711
SCYNEXIS INC · SCYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David C Hastings
Director
Period of report
Mar 8, 2018
Accepted (ET)
Mar 12, 2018 · 8:52 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 8, 2018 | P | 11,834 | $1.69 | A | 31,834 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrant (right to buy)F1 | $1.85 | Mar 8, 2018 | P | 8,875 | A | Mar 8, 2018 | Mar 14, 2019 | Common Stock | 8,875 | 8,875 | D |
| Common Stock Warrant (right to buy)F1 | $2.00 | Mar 8, 2018 | P | 5,325 | A | Mar 8, 2018 | Mar 8, 2023 | Common Stock | 5,325 | 5,325 | D |
Explanation of responses
- F1Reflects the purchase on March 8, 2018, of 11,834 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant).